Predictors of HBsAg loss after cessation of nucleo (s)tide analogue therapy in asian patients with low HBsAg levels

被引：0

作者：

Sonneveld, Milan ^{[1
]}

Chiu, S. M. ^{[2
]}

Park, Jun Yong ^{[3
]}

Kaewdech, Apichat ^{[4
]}

Seto, Wai-Kay ^{[5
]}

Tanaka, Yasuhito ^{[6
]}

Carey, Ivana ^{[7
]}

Papatheodoridi, Margarita ^{[8
]}

van Bommel, Florian ^{[9
]}

Brakenhoff, Sylvia ^{[1
]}

Berg, Thomas ^{[9
]}

Zoulim, Fabien ^{[10
]}

Ahn, Sang Hoon ^{[3
]}

Dalekos, George ^{[11
]}

Erler, Nicole ^{[1
]}

Zu Siederdissen, Christoph Hoener ^{[12
]}

Wedemeyer, Heiner ^{[12
]}

Cornberg, Markus ^{[12
]}

Yuen, Man-Fung ^{[5
]}

Agarwal, Kosh ^{[7
]}

Boonstra, Andre ^{[1
]}

Buti, Maria ^{[13
]}

Piratvisuth, T. ^{[4
]}

Papatheodoridis, George ^{[8
]}

Chen, Chien-Hung ^{[2
]}

Maasoumy, Benjamin ^{[12
]}

机构：

[1] Erasmus MC, Rotterdam, Netherlands

[2] Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan

[3] Yonsei Univ, Coll Med, Seoul, South Korea

[4] Prince Songkla Univ, Tambon Kho Hong, Thailand

[5] Univ Hong Kong, Hong Kong, Peoples R China

[6] Kumamoto Univ, Kumamoto, Japan

[7] Kings Coll Hosp London, London, England

[8] Laiko Hosp, Athina, Greece

[9] Univ Hosp Leipzig, Leipzig, Germany

[10] Inserm, Lyon, France

[11] Gen Univ Hosp Larissa, Larisa, Greece

[12] Med Hsch, Hannover, Germany

[13] Hosp Univ Vall dHebron, Barcelona, Spain

来源：

JOURNAL OF HEPATOLOGY | 2022年 / 77卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

SAT344

引用

页码：S824 / S825

页数：2

共 50 条

[21] Switching to PegIFNα-2b leads to HBsAg loss in patients with low HBsAg levels and HBV DNA suppressed by NAs
Jing Huang
Ka Zhang
Wenli Chen
Jinyao Liao
Xiaodan Luo
Ren Chen
Scientific Reports, 7
[22] Switching to PegIFNα-2b leads to HBsAg loss in patients with low HBsAg levels and HBV DNA suppressed by NAs
Huang, Jing
Zhang, Ka
Chen, Wenli
Liao, Jinyao
Luo, Xiaodan
Chen, Ren
SCIENTIFIC REPORTS, 2017, 7
[23] Low HBV DNA and HBsAg levels at 24 weeks off-treatment predict sustained response and HBsAg loss in patients who discontinued antiviral therapy
Sonneveld, Milan
Chiu, S. M.
Park, Jun Yong
Brakenhoff, Sylvia
Kaewdech, A.
Seto, Wai-Kay
Tanaka, Yasuhito
Carey, Ivana
Papatheodoridi, Margarita
Colombatto, Piero
van Bommel, Florian
Berg, Thomas
Zoulim, Fabien
Ahn, Sang Hoon
Dalekos, George
Erler, Nicole
Brunetto, Maurizia
Wedemeyer, Heiner
Cornberg, Markus
Yuen, Man-Fung
Agarwal, Kosh
Boonstra, Andre
Buti, Maria
Piratvisuth, Teerha
Papatheodoridis, George
Chen, Chien-Hung
Maasoumy, Benjamin
JOURNAL OF HEPATOLOGY, 2023, 78 : S1134 - S1134
[24] Mapping the HBsAg immune phenotype to predict HBsAg decline in chronic hepatitis B in patients receiving nucleot(s)ide analogue therapy
Lim, L. Y.
Yuen, L.
Hammond, R.
Angus, P. W.
Thompson, A. J.
Patterson, S. J.
Leary, T.
Yi, P.
Thomas, H.
Locarnini, S.
Walsh, R.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 154 - 154
[25] INCIDENCE AND PREDICTIVE FACTORS OF HBsAg LOSS IN HBEAG-POSITIVE PATIENTS WHO STOP NUCLEOT(S)IDE ANALOGUE THERAPY
Peng, Chien-Wei
Jeng, Wen-Juei
Liu, Yen-Chun
Chien, Rong-Nan
Liaw, Yun-Fan
HEPATOLOGY, 2022, 76 : S320 - S320
[26] PREDICTION OF HBSAG LOSS USING HBSAG DECLINE AFTER LONG-TERM VIROLOGICAL RESPONSE TO NUCLEOS(T)IDE ANALOGUE THERAPY FOR CHRONIC HEPATITIS B
Zoutendijk, Roeand
Hansen, Bettina E.
van Vuuren, Anneke J.
Boucher, Charles A.
Janssen, Harry L.
HEPATOLOGY, 2010, 52 (04) : 509A - 509A
[27] PegIFN alpha-2a reduces relapse in HBeAg-negative patients after nucleo(s)tide analogue cessation: A randomized-controlled trial
Li, Fahong
Qu, Lihong
Liu, Yanhong
Wu, Xiaoping
Qi, Xun
Wang, Jinyu
Zhu, Haoxiang
Yang, Feifei
Shen, Zhongliang
Guo, Yifei
Zhang, Yongmei
Yu, Jie
Mao, Richeng
Zhang, Qiran
Zhang, Fengdi
Chen, Liang
Huang, Yuxian
Zhang, Xinxin
Li, Qingxing
Zhang, Wenhong
Zhang, Jiming
JOURNAL OF HEPATOLOGY, 2025, 82 (02) : 211 - 221
[28] OFF- TREATMENT HBSAG AND HBV DNA LEVELS PREDICT OUTCOMES AFTER THERAPY WITHDRAWAL AMONG PATIENTS WITH HIGH HBSAG LEVELS AT END OF TREATMENT
Sonneveld, Milan J.
Chiu, S. -M.
Park, Jun Yong
Brakenhoff, Sylvia
Kaewdech, Apichat
Seto, Wai-Kay
Tanaka, Yasuhito
Carey, Ivana
Papatheodoridi, Margarita
Colombatto, Piero
Van Boemmel, Florian
Janssen, Harry L. A.
Berg, Thomas
Zoulim, Fabien
Ahn, Sang Hoon
Dalekos, George N.
Erler, Nicole S.
Brunetto, Maurizia R.
Wedemeyer, Heiner
Cornberg, Markus
Yuen, Mf
Agarwal, K.
Boonstra, Andre
Buti, Maria
Piratvisuth, Teerha
Papatheodoridis, George V.
Chen, Chien Hung
Maasoumy, Benjamin
HEPATOLOGY, 2023, 78 : S535 - S537
[29] Probability of HBsAg loss after nucleos(t)ide analogue withdrawal depends on HBV genotype and viral antigen levels
Deng, Rui
Fan, Rong
Sun, Jian
JOURNAL OF HEPATOLOGY, 2022, 77 (04) : 1223 - 1224
[30] PREDICTORS OF HBSAG LOSS IN HIV- HBV COINFECTED PATIENTS RECEIVING ANTIRETROVIRAL THERAPY: A SYSTEMATIC REVIEW
Rahman, Mansoor
Rehman, F. N. U. Khalil Ur
Usama, Fatima
Hassam, Khawaja
Rasikh, Rohullah
Shah, Syed Bilal
Ullah, Ashraf
Ullah, Zabeeh
Khan, Abu Baker
Lau, Daryl
HEPATOLOGY, 2024, 80 : S333 - S334

← 1 2 3 4 5 →